These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37378536)

  • 1. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
    Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
    Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
    Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients.
    Yetmar ZA; Bhaimia E; Razonable RR
    Curr Opin Organ Transplant; 2022 Aug; 27(4):269-276. PubMed ID: 36354253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023.
    Solera JT; Árbol BG; Mittal A; Hall V; Marinelli T; Bahinskaya I; Selzner N; McDonald M; Schiff J; Sidhu A; Humar A; Kumar D
    Am J Transplant; 2024 Jul; 24(7):1303-1316. PubMed ID: 38499087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
    Subramanian V
    J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients.
    Figueroa AL; Azzi JR; Eghtesad B; Priddy F; Stolman D; Siangphoe U; Leony Lasso I; de Windt E; Girard B; Zhou H; Miller JM; Das R
    J Infect Dis; 2024 Sep; 230(3):e591-e600. PubMed ID: 38513368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Outcomes and Vaccinations in Swedish Solid Organ Transplant Recipients 2020-2021: A Nationwide Multi-Register Comparative Cohort Study.
    Søfteland JM; Li H; Magnusson JM; Leach S; Friman V; Gisslén M; Felldin M; Schult A; Karason K; Baid-Agrawal S; Wallquist C; Nyberg F
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation-A Danish nationwide cohort study.
    Overvad M; Koch A; Jespersen B; Gustafsson F; Krause TG; Hansen CH; Ethelberg S; Obel N
    Am J Transplant; 2022 Nov; 22(11):2627-2636. PubMed ID: 35801493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.
    Jabr R; Khatri A; Anderson AD; Garcia LC; Viotti JB; Natori Y; Raja M; Camargo JF; Morris MI
    Transpl Infect Dis; 2023 Feb; 25(1):e14006. PubMed ID: 36704987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
    Sarrell BA; Bloch K; El Chediak A; Kumm K; Tracy K; Forbes RC; Langone A; Thomas L; Schlendorf K; Trindade AJ; Perri R; Wright P; Concepcion BP
    Transpl Infect Dis; 2022 Feb; 24(1):e13759. PubMed ID: 34787345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
    Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
    Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic.
    Yamanaga S; Shimata K; Ohfuji S; Yoshikawa M; Natori Y; Hibi T; Yuzawa K; Egawa H;
    Am J Transplant; 2024 Aug; 24(8):1495-1508. PubMed ID: 38514016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease 2019 (COVID-19) in Heart Transplant Recipients and Anti-SARS-CoV-2 Monoclonal Antibodies: Experience, Lessons Learnt, and Future Challenges.
    Kapur R; Okumura K; Ohira S; Isath A; Gandhi A; Keller M; Nog R; Gass A; Spielvogel D; Lansman S; Dhand A
    Cardiol Rev; 2024 Feb; ():. PubMed ID: 38334977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.
    Karaba AH; Zhu X; Benner SE; Akinde O; Eby Y; Wang KH; Saraf S; Garonzik-Wang JM; Klein SL; Bailey JR; Cox AL; Blankson JN; Durand CM; Segev DL; Werbel WA; Tobian AAR
    Transplantation; 2022 Apr; 106(4):835-841. PubMed ID: 35085183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
    Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
    Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.